First Time Loading...

Curis Inc
NASDAQ:CRIS

Watchlist Manager
Curis Inc Logo
Curis Inc
NASDAQ:CRIS
Watchlist
Price: 14.47 USD -0.34% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

CRIS Price Targets Summary
Curis Inc

Wall Street analysts forecast CRIS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRIS is 22.19 USD with a low forecast of 15.15 USD and a high forecast of 27.3 USD.

CRIS Lowest Forecast
Wall Street Target
15.15 USD
5% Upside
CRIS Average Forecast
Wall Street Target
22.19 USD
53% Upside
CRIS Highest Forecast
Wall Street Target
27.3 USD
89% Upside
Lowest
Price Target
15.15 USD
5% Upside
Average
Price Target
22.19 USD
53% Upside
Highest
Price Target
27.3 USD
89% Upside
Curis Inc Competitors:
Price Targets
LEGN
Legend Biotech Corp
94% Upside
MRKR
Marker Therapeutics Inc
197% Upside
6855
Ascentage Pharma Group International
85% Upside
DTIL
Precision BioSciences Inc
289% Upside
LEGN
Legend Biotech Corp
94% Upside
MRKR
Marker Therapeutics Inc
197% Upside
6855
Ascentage Pharma Group International
85% Upside
DTIL
Precision BioSciences Inc
289% Upside
SNPX
Synaptogenix Inc
209% Upside
ELYM
Eliem Therapeutics Inc
13% Upside
I
IVVD
Invivyd Inc
345% Upside
G
144510
GC Cell Corp
97% Upside

Revenue
Forecast

Revenue Estimate
Curis Inc

For the last 8 years the compound annual growth rate for Curis Inc's revenue is 3%. The projected CAGR for the next 3 years is 10%.

3%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Curis Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Curis Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
CRIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRIS stock valuation using valuation multiples.
Wall Street Estimates
CRIS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRIS's stock price target?
Price Target
22.19 USD

According to Wall Street analysts, the average 1-year price target for CRIS is 22.19 USD with a low forecast of 15.15 USD and a high forecast of 27.3 USD.

What is Curis Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Curis Inc's revenue is 3%. The projected CAGR for the next 3 years is 10%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.